XML 22 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Revenue Recognition and Accounts Receivables
3 Months Ended
Sep. 30, 2016
Receivables [Abstract]  
Revenue Recognition and Accounts Receivables

Note 6. – Revenue Recognition and Accounts Receivables

The Company’s subsidiaries recognize revenues in the period in which services are provided. Accounts receivable primarily consist of amounts due from third-party payors and patients. The Company’s subsidiaries’ ability to collect outstanding receivables is critical to their results of operations and cash flows. Amounts the Company’s subsidiaries receive for treatment of patients covered by governmental programs such as Medicare and Medicaid and other third-party payors such as health maintenance organizations (“HMOs”), preferred provider organizations (“PPOs”) and other private insurers are generally less than the Company’s subsidiaries’ established billing rates. Additionally, to provide for accounts receivable that could become uncollectible in the future an allowance for doubtful accounts is established to reduce the carrying value of such receivables to their estimated net realizable value. Accordingly, the revenues and accounts receivable reported in the accompanying unaudited condensed consolidated financial statements are recorded at the net amount expected to be received.

Revenues by payor were as follows for the three months ended September 30, 2016 and 2015:

 

     Three Months Ended  
     September 30,  
     2016      2015  

Healthcare Facilities Segment:

     

Medicare

   $ 2,033       $ 3,509   

Medicaid

     2,496         2,922   

Self-pay

     119         645   

Managed Care & Other Insurance

     720         2,402   

Other

     22         33   
  

 

 

    

 

 

 

Revenues before provision for doubtful accounts

     5,390         9,511   

Provision for doubtful accounts

     (33      (716
  

 

 

    

 

 

 

Healthcare Facilities Segment Net Revenues

     5,357         8,795   

Pharmacy Segment Net Revenues

     7,341         7,567   

Other Revenues

     348         222   
  

 

 

    

 

 

 

Total Net Revenues

   $ 13,046       $ 16,584   
  

 

 

    

 

 

 

The net revenues of the Pharmacy Segment are presented net of contractual adjustments. The provision for bad debts of the Pharmacy Segment is presented as a component of operating expenses in the Condensed Consolidated Statements of Operations and Comprehensive Loss.

Summary information for accounts receivable is as follows:

 

     September 30,      June 30,  
     2016      2016  

Accounts receivable (net of contractual allowances)

   $ 6,698       $ 7,157   

Less allowance for doubtful accounts

     (792      (991
  

 

 

    

 

 

 

Patient accounts receivable - net

   $ 5,906       $ 6,166   
  

 

 

    

 

 

 

 

The following is a summary of the activity in the allowance for doubtful accounts for the Healthcare Facilities Segment and the Pharmacy Segment for the three months ended September 30, 2016 and 2015:

 

Three Months Ended September 30, 2016,    Healthcare
Facilities
     Pharmacy      Total  

Balance at July 1, 2016

   $ 624       $ 367       $ 991   

Additions recognized as a reduction to revenues:

        

Continuing Operations

     33         91         124   

Discontinued Operations

     407         —           407   

Accounts written off, net of recoveries

     (662      (68      (730
  

 

 

    

 

 

    

 

 

 

Balance at September 30, 2016

   $ 402       $ 390       $ 792   
  

 

 

    

 

 

    

 

 

 
Three Months Ended September 30, 2015,    Healthcare
Facilities
     Pharmacy      Total  

Balance at July 1, 2015

   $ 4,962       $ 385       $ 5,347   

Additions recognized as a reduction to revenues:

        

Continuing Operations

     715         222         1,004   

Discontinued Operations

     1,017         —           950   

Accounts written off, net of recoveries

     (1,913      (163      (2,076
  

 

 

    

 

 

    

 

 

 

Balance at September 30, 2015

   $ 4,781       $ 444       $ 5,225